Evidence map›Paper›PMID 40922673›Full record

ReviewJournal of obesity & metabolic syndrome2025

Multimodal and Multidimensional Artificial Intelligence Technology in Obesity.

Hyeseung Lee, Jiyoung Hwang, Dong Keon Yon, Sang Youl Rhee

Abstract readReview
In one paragraph

Review in Journal of obesity & metabolic syndrome, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Hyeseung LeeDepartment of Medicine, College of Medicine, Kyung Hee University, Seoul, Korea.
Jiyoung HwangDepartment of Medicine, College of Medicine, Kyung Hee University, Seoul, Korea.
Dong Keon YonDepartment of Medicine, College of Medicine, Kyung Hee University, Seoul, Korea.ORCID https://orcid.org/0000-0003-1628-9948
Sang Youl RheeDepartment of Medicine, College of Medicine, Kyung Hee University, Seoul, Korea.ORCID https://orcid.org/0000-0003-0119-5818

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although the prevalence of obesity is increasing worldwide, related treatment remains a complex challenge that requires multidimensional approaches. Recent advancements in artificial intelligence (AI) have led to the development of multimodal methods capable of integrating diverse types of data. These AI approaches utilize both multimodal data integration and multidimensional feature representations, enabling personalized, data-driven strategies for obesity management. AI can support obesity management through applications such as risk prediction, clinical decision support systems, large language models, and digital therapeutics. Several studies have shown that these AI-based weight loss programs can achieve significant weight reduction and behavioral changes. These AI systems can induce behavioral modifications through continuous personalized feedback and improve accessibility for people in underserved areas. However, these AI technologies must address issues such as data privacy and security, transparency and accountability, and consider the potential widening health disparities between individuals who have access to AI technology and those who do not, as well as strategies for sustained user engagement. Conducting long-term clinical trials and evaluations of cost-effectiveness across diverse, large-scale populations would facilitate the effective application of AI in obesity management, ultimately contributing to improvements in public health.

Indexed as

Artificial intelligenceDelivery of health careMachine learningObesityObesity management

Identifiers

PMID40922673
PMCPMC12583783

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.